January 8, 2018 • VitaCann Pty Ltd (“VitaCann” subsidairy) has signed an exclusive joint venture agreement (the “Joint Venture”) for a World First Pharmaceutical Grade Medical Cannabis Extended Release Pill with Canntab Therapeutics Limited (“Canntab”) of Toronto,Canada.,
The Board at Queensland Bauxite (ASX:QBL) is excited with the recent success and progress of its investment in Medical Cannabis Ltd (“MCL” or “the Company”), particularly as the medicinal focused arm of that Company, Vitacann, has signed a Letter of Intent for a joint venture subject to full documentation with an Israeli recommended group of North American chemists who have put together what we understand to be a world first in the Medical Cannabis industry. Read More;
MCL and AEB join to develop Cannabis veterinary medications; The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited’s Low THC Delta 9 Cannabis cultivars from the uniqu...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.